Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Pharmalot
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Merck shocks with CETP cholesterol study win; Ra Pharma’s scant PNH data

  • Adam Feuerstein

By Adam Feuerstein June 27, 2017

Reprints

Welcome to Readout Markets, where I’ll deliver news, analysis, and market chatter from the corner of biotech and Wall Street. Keep checking back, as I’ll be updating throughout the day.

Updated at 4:17 pm EDT

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Tags

‘I’m terrified’: Patients scramble for treatment after 13 ketamine…
‘I’m terrified’: Patients scramble for treatment after 13 ketamine clinics shut down
5 ways to address the shortage of health care…
5 ways to address the shortage of health care workers
When a patient nears the end, a feared therapy…
When a patient nears the end, a feared therapy can also comfort
J&J loses a patent battle in India over a…
J&J loses a patent battle in India over a crucial tuberculosis drug
Listen: Bancel v. Bernie, Sarepta’s FDA runaround, & Regeneron’s…
Listen: Bancel v. Bernie, Sarepta’s FDA runaround, & Regeneron’s ever-growing blockbuster
Pharmalittle: FDA panel backs conditional approval for Biogen ALS…
Pharmalittle: FDA panel backs conditional approval for Biogen ALS drug; pharma fights tactic for lowering specialty…

Recommended Stories